Although GLP-1Ra and other medications for weight loss have transformed obesity treatment, their impact on bone health remains largely unexplored [13].Effects of GLP-1 receptor agonists on bone health in preclinical models.
Results A total of 17 studies were analyzed that addressed the impact of GLP-1 receptor agonists on bone health, bone and joint infections, and postoperative outcomes.
Research on the impact of GLP-1 agonists on bone mineral density is still developing but shows promising results. A study indicated that patients treated with GLP-1RAs exhibited an increase in bone mineral density (BMD) compared to those not receiving these medications.
risk of bone fractures has led to the investigation of the impact of. antidiabetic drugs on bone metabolism. Glucagon-like peptide-1 receptor. agonists (GLP1RAs) are a relatively novel and promising class of anti
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) for the treatment of type 2 diabetes mellitus: friends or foes to bone health? a narrative review of clinical studies.
(2021). Effects of GLP-1 Receptor Agonists on bone mineral density in patients with type 2 diabetes mellitus: A 52-week clinical study.(2017). The impact of Glucagon-Like Peptide-1 on bone metabolism and its possible mechanisms. Front Endocrinol (Lausanne), 8.
If you want to learn more about what are the effects of GLP-1 agonists on different diseases and GLP-1 agonists , you can visit: https://join.jaycampbell.com...
